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Abstract
Background: Increased Serum insulin-like growth factor-1 (S-IGF-1) has been noted after physical activity in healthy
subjects, while the acute release of S-IGF-1 in relation to exercise has not previously been studied in women with
fibromyalgia (FM). S-IGF-1 and its binding protein (S-IGFBP-3) are mediated by growth hormone and have anabolic
effects on the skeletal muscle. Aim of the study was to investigate acute release of IGF-1 after aerobic exercise in
women with FM.
Methods: The acute effect of physical exercise on S-IGF-1 and S-IGFBP-3 were studied in 22 women with FM and
in 27 healthy controls during moderate and high-intensity cycling (i.e. ratings 12–13 and 15–17, on Borg’s perceived
exertion scale (RPE), respectively). Self-reported pain and fatigue were recorded. Differences within and between the
two groups were analyzed.
Results: After 15 min of bicycling, S-IGF-1 and S-IGFBP-3 increased both within the group with FM and in the
healthy controls (p < 0.01). The increases in S-IGF-1 did not significantly differ between the women with FM and the
healthy control group (mean increase 11 ± 10 vs. 11 ± 15 ng/ml and 13 ± 10 vs. 19 ± 22 ng/ml) when bicycling at
moderate or high intensity, respectively. Self-reported pain and fatigue during exercise, irrespective of intensity,
were higher in women with FM compared with healthy controls (p < 0.001).
Conclusions: Fifteen minutes bicycling at moderate intensity was sufficient to acutely mobilise S-IGF-1 in women
with FM similarly to healthy controls in spite of higher score of fatigue and pain in women with FM. Hence,
patients with FM were able to activate their skeletal muscle metabolism during a short, moderate bout of exercise
and were not resistant to training effects. The result is important for encouraging clinical rehabilitation of patients
with FM who commonly exercise at a moderate, rather than at a high-intensity level.
Trial registration: ClinicalTrials.govNCT01592916, May 4, 2012.
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Background
Fibromyalgia (FM) is characterised by persistent wide-
spread pain and increased pain sensitivity and tender-
ness [1], and is associated with impaired physical fitness
[2]. Pain in FM is attributed to central sensitization and
impaired pain inhibition [3], implying that the pain in-
creases during physical activities. Activity-induced pain
in FM [4] is a probable reason why persons with FM
commonly prefer physical activities of low, rather than
of high intensity [5, 6].
Studies have shown that physical capacity can be im-
proved through exercise in patients with FM [7]. There are,
however, several factors, such as age, sex, health and hor-
monal status, inflammation and nutrition that can influence
the effect of exercise. Growth hormone has been of special
interest in research of FM, due to documented disturbance
in the pituitary growth hormone axis in FM, especially in
persons with severe symptoms [8, 9]. Growth hormone is
influenced by several factors, such as sleep, stress, nutrition,
smoking, body composition and physical activity [10].
Growth hormone exerts its effect via the insulin-like
growth factor (IGF) system in the liver including total and
free IGF-,1 IGF-2 and six binding proteins (IGFBP) of
which IGF-1 and IGFBP-3 are most important in the skel-
etal muscle [11] with positive outcomes of exercise [12] .
Furthermore, exercise has beneficial effects in the central
nervous system via uptake of peripheral IGF-1 [13]. S-IGF-
1 increased in lean women with FM, but not in overweight
counterparts, after aerobic exercise twice weekly during
15 weeks [14].
Acute release of IGF-1 in relation to exercise has not
previously been studied in women with FM. The aim was
to study the effects of short bouts of aerobic exercise of
moderate and high intensities, respectively, on S-IGF-1 in
women with FM in comparison with healthy controls.
Methods
Study design: an experimental study
Study population
Women with FM, aged 20 to 50 years, and fulfilling the
American College of Rheumatology criteria for FM [1] and
healthy women without FM, aged 20 to 50 years, were eli-
gible for the exercise intervention. Eligible patients were
identified among those having participated in previous stud-
ies, contacted by telephone and asked about their interest of
participating in the study. Healthy controls were recruited
among employees at the hospital and university settings to
participate in the same exercise tests. All patients and con-
trols should be able to participate in two bicycle tests at
8–12 o’clock at the 5–7th day of the menstrual cycle.
Exclusion criteria were concomitant severe diseases
hindering participation in the exercise tests, such as high
blood pressure, a cardiovascular disease, severe osteo-
arthritis, psychiatric disease.
Study procedures
The study protocol was described, days for planned ex-
aminations were presented, and if matching the volun-
teer’s schedule, the first test occasion was booked. A
patient information sheet was sent to the volunteers.
Participation involved two visits and the participants
were told to reserve 1.5 h for each visit. The two exercise
tests were separated by a month. The tests were con-
ducted during mornings at the 5–7th day of the men-
strual cycle, to control for the hormonal status. Subjects
not being able to return after 1 month were offered pos-
sibility to do the test after 2 months. Subjects complet-
ing both tests were included in the statistical analyses.
Before the examination, verbal information was given
and an informed consent was signed by the test person
and the nurse. The first blood test was sampled in the
fasting state, after which a light standardized breakfast (a
cheese sandwich, caffeine-free coffee or tea) was served.
Information about demographic data and pharmaco-
logical treatment was gathered by an interview, and the
test person was asked to fill in a questionnaire about
health status, symptoms and physical activity habits.
Body composition was evaluated with body weight (kg)
and height (m) in light clothes without shoes for calcula-
tion of body mass index (BMI) as body weight divided
by height squared (kg/m2). Furthermore, bioimpedance,
(SEAC Multiple frequency bioimpedance meter model
SFB 2, UniQuest Ltd, Queensland, Australia) was per-
formed. This method is based on resistance and react-
ance in the total body. The method measures the
intracellular and extracellular resistance and the body fat
and fat-free or lean mass can be derived in relation to
height, body weight and age [15, 16].
The number of tender points to verify the ACR criteria
[1] for FM was calculated.
The two exercise tests on an ergometer cycle
The exercise tests were conducted on a Monark ergometer
cycle model 829 E (Monark, Vansbro, Sweden) and the load
for each patient was chosen after an interview regarding
the participant’s physical activity level to fit a given level on
the Borg’s scale of perceived exertion (RPE scale) [17].
Heart rate, blood pressure and rate of perceived exertion
[17] were monitored during the test. After 15-min of erg-
ometer cycle test, the second blood test was sampled, after
which the test person was asked to rate her pain and fa-
tigue. Similar examinations were conducted after 30 min of
rest (0–45 min).
Ergometer cycle test of moderate and high intensities
A 15-min test on a ergometer bicycle [18] was per-
formed and the participant was asked to rate her exer-
tion on RPE scale. Moderate intensity was defined as
12–13 and high 15–17 on the RPE-scale, respectively
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[17]. During the first test the patients also mentally ad-
justed themselves to manage the second test.
Exercise load
The load (watt) during ergometer cycling was monitored
every other minute and adjusted to fit the participant’s
perceived exertion level: i:e: 12–13 or 15–17, respect-
ively, on the RPE-scale. The loads (watts) during the test
performance were transformed to kilojoules to represent
the total work during the test performance.
Pain threshold was examined by using an algometer
(Somedic Production AB, Sollentuna, Sweden), mea-
sured in kilopascals (kPa) [19]. The pain threshold was
measured in two tender-point locations in the upper and
lower extremities, respectively: musculus trapezius, mus-
culus supraspinatus, musculus gluteus and medial fat
pad of the knee [1] . The mean value was applied, and a
higher value indicated a better health.
Pain and fatigue were rated on a visual analogue scale
(0–100; low to high). A higher score indicates more se-
vere pain or fatigue.
Health status was assessed by the Fibromyalgia Impact
Questionnaire (FIQ), a higher score indicating more se-
vere impairment [20].
Blood sampling
Serum samples were collected from the cubital vein in the
fasting state at rest at baseline (0), after 15 min cycling
and 30 min of rest after the bicycling was terminated
(45 min). Biological markers were analyzed by sandwich
enzyme-linked immunosorbent assays (ELISAs) using a
pair of specific antibodies for human interleukin 8
(M1918, 1.0 pg/ml, Sanquin reagents, Amsterdam, the
Netherlands). ELISAs were read with a Spectramax 340
from Molecular Devices (Sunnyvale, CA, USA). Human
high sensitivity C-reactive protein (sCRP, ref < 5 μg/ml)
was analyzed by immunoturbidimetic analysis by the
accredited Laboratory for Clinical Chemistry at the
Sahlgrenska University Hospital, Gothenburg, Sweden.
Total S-IGF-1 was measured by solid-phase, enzyme-
labeled chemoluminescent immunoassay with IDS-iSYS
IGF1 immunoassay (IS-3900, Immunodiagnostic Systems
Boldon, UK), S-IGFBP-3 and free IGF-1 with reagents
from DY675, RnD Systems, Minneapolis, MN, USA.
Statistics
Non-parametric statistic tests were chosen due to small
sample sizes. Descriptive data were presented as mean
and SD or median and range. Differences within a group
were analyzed by the Wilcoxon signed rank test and be-
tween the groups with Mann Whitney U-test. Fischer’s
exact test was applied in the analysis of categorical data.
Relations between the variables were examined with the
Spearman’s correlation test. All significant tests were




A total of 28 women with FM were screened for the
study. Three of them did not fulfill the American
College of Rheumatology 1990 criteria for FM and one
had a high blood pressure, leaving 24 patients. Two pa-
tients withdrew themselves from the study due to time
limitations. Thus, the patient population comprised 22
women with FM, with the mean age of 44 (range 33–50)
years. The healthy reference group for the exercise tests
comprised 27 women, mean age 44 years (range 29–50)
years (ns). Anthropometric and background data are
given in Table 1.
Exercise performance at moderate intensity
Rating of perceived exertion (RPE) No significant dif-
ference was found for perceived exertion between the
two groups. The mean scoring at 15-min of cycling was
14.9 ± 1.6 in the FM-group, while it was 14.2 ± 1.9 in the
reference group (p = 0.310).
Exercise load in women with FM at 15 min was
48 ± 20 Watt (W), while it was 94 ± 27 W in the ref-
erence group (p < 0.001). The heart rate at 15 min
was 114 ± 16 beats/min in those with FM and 137 ± 18
beats/min in the healthy group (p < 0.001). Total work in
the group with FM at 15 min was 34 ± 11 kJ (kJ), while it
was 66 ± 12 kJ in the reference group (p < 0.001).
Exercise performance at high-intensity
Rating of perceived exertion (RPE) No significant dif-
ference was found for perceived exertion between the
two groups. The mean RPE was 17.3 ± 1.6 in the FM-
group and 16.6 ± 1.5 in the healthy group (p = 0.85).
Exercise load in the group with FM at 15 min was
93 ± 25 W, while it was 127 ± 28 W in the healthy control
group, implying that the latter group exercised at a
significantly higher work load (p < 0.001). The heart rate
at 15 min was 147 ± 20 beats/min in the FM-group and
160 ± 18 beats/min in the healthy group (p = 0.028). Total
work in the FM-group at 15 min was 62 ± 15 kJ, while it
was 91 ± 17 kJ in the reference group (p < 0.001). Total
work was significantly higher in high intensity compared
to moderate intensity both in the FM–group (p < 0.001)
and in the reference group (p < 0.001).
Change in S-IGF-1
S-IGF-1 was similar in women with FM and controls at
baseline and increased similarly in both groups, during
the two exercise intensities. Mean response of S-IGF-1
was 6% in patients with FM during both the moderate
and the high-intensity exercise. Mean response of
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IGF-1-t in the reference group was 7% during the
moderate intensity exercise and 10% during the high-
intensity exercise (ns between patients and controls),
(Tables 2 and 3).
Change in S-IGFBP-3and free IGF-1
S-IGFBP-3 and free IGF-1 were similar in the two
groups of women at baseline. S-IGFBP-3 increased
and free IGF-1 decreased significantly during the two
exercise intensities in women with FM and in con-
trols (ns between groups), (Tables 2 and 3).
Change in IL-8 and sCRP
Serum IL-8 was similar in women with FM and controls
at baseline and did not change during the exercise in
any of the two groups (Tables 2 and 3).
sCRP levels were higher in women with FM compared
with controls at baseline. sCRP increased during both
Table 1 Background data for women with fibromyalgia (FM) and the healthy reference group
Women with FM, n = 22 Reference group, n = 26 p-value
Mean SD Range Mean SD Range
Age, year 44 4 33–50 44 5 29–50 0.808
BMI, kg/m2 28.2 5.3 20.5–38.9 23.2 2.7 18.8–31.2 <0.001
Fat, kg 28.3 12.0 11–51 17.6 8.0 4–40 0.001
Fat free mass, kg 47.8 7.0 38–63 47.9 5.4 39–60 0.695
Tender points, 0–18 13 1.8 11–16 0 0 0 <0.001
Pain localisations, 0–18 13 3.4 6–18 1.0 1.4 0–5 <0.001
Algometry, kPa 255 56 167–403 378 107 173–566 <0.001
Smoking, yesa N = 2 0–2 N = 0 0 0.186
Sleep quantity, 1–4 2.8 0.9 1–4 2.1 0.6 1–3 0.003
Sleep quality, 1–4 2.6 0.7 1–4 1.6 0.6 1–3 <0.001
Work hours, 0–40 27 10.5 0–40 37 5.0 20–40 <0.001
FIQ total score, 0–100 48 16 10–73 9 9 0–28 <0.001
Hand force, maximum, right hand, N 215 83 67–381 252 60 130–396 0.129
LTPAI, hours/week 5.3 3.5 1–17 7.0 4.2 1–16 0.170
LTPAI, hard, hours/week 0.6 1.3 0–6 1.4 1.4 0–6 0.024
FIQ Fibromyalgia Impact Questionnaire, LTPAI Leisure Time Physical Activity Instrument, Algometry = pain threshold
aInformation from one subject with FM was missing
Table 2 Values obtained at moderate intensive exercise performance in women with fibromyalgia (FM) and the healthy reference
group. Mean value and SD for baseline values, differences (Δ), p-value for within-group differences as well as for between- group
differences are presented
Moderate intensity exercise performance
Women with FM, n = 22 Healthy reference group, n = 27 Between-group differences
0 min 15 min–0 min 0 min 15 min–0 min 0 min Change 0–15 min
Mean ± sd Δ mean ± sd p-value Mean ± sd Δ mean ± sd p-value p-value p-value
S-IGF-1 (ng/ml) 178 ± 58 11 ± 10 <0.001 179 ± 69 13 ± 10 <0.001 0.825 0.629
free IGF-I (ng/ml) 3.5 ± 1.6 −0.15 ± 0.34 0.014 4.0 ± 2.09 −0.38 ± 0.47 <0.001 0.457 0.119
S-IGFBP3 (ng/ml) 428 ± 44 11 ± 16 0.007 426 ± 37 14 ± 19 0.001 0.880 0.662
sCRP (μg/ml) 2.0 ± 2.2 0.14 ± 0.18 0.001 0.56 ± 0.48 0.35 ± 0.46 <0.001 <0.001 0.215
IL-8 (pg/ml) 9.2 ± 4.5 −5.9 ± 1.6 0.105 9.6 ± 2.5 −0.3 ± 1.0 0.077 0.769 0.600
Pain (0–100 mm) 40 ± 19 7.6 ± 16 0.044 0.8 ± 2.1 2.0 ± 6.8 0.093 <0.001 0.015
Fatigue in legs (0–100 mm) 26 ± 23 28 ± 24 <0.001 1 ± 2.4 6.0 ± 8.5 0.002 <0.000 <0.001
Fatigue global (0–100 mm) 51 ± 27 9.2 ± 17 0.038 4 ± 6.4 10 ± 12 0.002 <0.001 0.672
S-IGF-1 serum insulin-like growth factor-1, S-IGFBP3 Insulin-like growth factor binding protein-3, sCRP human high sensitivity C-reactive protein, IL-8 interleukin-8
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exercise intensities in both groups (ns between groups),
(Tables 2 and 3).
Body composition
Body mass index and body fat were higher in women
with FM. However, lean mass was similar (Table 1). Lean
mass did not correlate with S-IGF-1 (p = 0.200) in any
group.
In women with FM, body fat was correlated with pain
(r = 0.434, p = 0.044, n = 22) and global fatigue (r = 0.57,
p = 0.006, n = 22) at 15 min of high intensity exercise
and the level of sCRP (r = 0.487, p = 0.022, n = 22). BMI
correlated with global fatigue at 15 min of exercise
(r = 0.514, p = 0.014, n = 22) and sCRP level (r = 0.465,
p = 0.029, n = 22) and tended to correlate negatively
with baseline levels of S-IGF (r = −0.415, p = 0.055) in
women with FM. BMI or body fat did not correlate
with change in S-IGF-1 at moderate or high intensity
exercise, respectively, in women with FM.
Pain
Patients with FM reported more pain at baseline when
compared to the reference group (p < 0.001). Pain in-
creased more in the women with FM during the moder-
ate intensity exercise (Table 2), while there was no
difference for change between the two groups during the
high-intensity exercise (Table 3).
Pain threshold
Women with FM had significantly lower pain threshold
measured with algometry at baseline, on both exercise oc-
casions, when compared to the reference group (Table 1).
No significant difference was found (p = 0.66) when the
baseline pain thresholds at the first and the second test
occasion were compared within the FM-group. Pain
thresholds decreased in the FM-group after moderate
(−25 ± 20, p < 0.0001) and tended to decrease after high
intensity exercise (−12 ± 28, p = 0.08). Pain thresholds
increased after high (17 ± 38, p = 0.02) but not after
moderate intensity exercise in controls.
Fatigue in the legs, global fatigue
Women with FM reported more fatigue in the legs as
well as global fatigue at baseline when compared to the
reference group (p < 0.001). Fatigue in the legs increased
during both exercise intensities in both groups and was
more pronounced in the FM-group than in the reference
groups. Global fatigue increased in both groups during
both exercise intensities, (ns between the two groups),
(Tables 2 and 3).
Discussion
Growth hormone derived S-IGF-1 and its binding pro-
tein S-IGFBP-3 increased after moderate exercise during
15 min on an ergometer cycle in women with FM simi-
lar to women in the healthy reference group in spite of
more reported pain and fatigue in FM. The mean in-
crease in S-IGF-1 was in line with previous reports from
healthy individuals [21, 22].
Exercise mobilises systemic IGF-1 from the liver and lo-
cally in skeletal muscle. Growth hormone is the main
stimulus for hepatic IGF-1 production in the resting state
but there is a delay of several hours of growth hormone-
mediated release of hepatic IGF-1 post-exercise [23, 24].
This indicates that the increase in S-IGF-1 in this study
was growth hormone-independent. It has been shown that
circulating IGF-1 is mobilised from active muscles during
intense exercise [11, 25].
A higher level of S-IGF-1 has been associated with
better physical fitness among both younger [26] and
Table 3 Values obtained at high-intensity exercise performance in women with fibromyalgia (FM) (n = 22) and the healthy reference
group (n = 27). Mean value and SD of differences (Δ), p-value for within-group differences as well as for between- group differences
are presented
High-intensity exercise
Women with FM, n = 22 Healthy reference group, n = 27 Between-group differences
0 min 15 min–0 min 0 min 15 min–0 min 0 min Change 0–15 min
Mean ± sd Δ mean ± sd p-value Mean ± sd Δ mean ± sd p-value p-value p-value
S-IGF-1 (ng/ml) 195 ± 60 11 ± 15 <0.001 181 ± 66 19 ± 22 <0.001 0.244 0.560
Free IGF-1 (ng/ml) 4.7 ± 2.6 −0.42 ± 0.48 0.014 4.7 ± 3.2 −0.56 ± 0.76 <0.001 0.755 0.843
S-IGFBP3 (ng/ml) 556 ± 75 25 ± 37 0.009 614 ± 91 25 ± 41 0.008 0.037 0.942
sCRP μg/ml) 2.1 ± 2.4 0.06 ± 0.16 0.002 0.70 ± 0.77 0.04 ± 0.06 <0.001 0.001 0.119
IL-8 (pg/ml) 7.5 ± 3.0 0.7 ± 2.9 0.545 9.7 ± 4.2 −0.2 ± 1.9 0.673 0.107 0.565
Pain (0–100, mm) 46 ± 24.4 −4.0 ± 16.1 0.291 2.4 ± 7.4 0 ± 3.6 0.878 <0.001 0.139
Fatigue in legs (0–100 mm) 31 ± 21 28 ± 20 <0.001 1.2 ± 3.1 12 ± 13 <0.001 <0.001 0.003
Fatigue global (0–100 mm) 50 ± 24 8.4 ± 19 0.007 3.0 ± 5.3 6.3 ± 10 <0.001 <0.001 0.414
S-IGF-1 serum insulin-like growth factor-1, S-IGFBP3 Insulin-like growth factor binding protein-3, sCRP human high sensitivity C-reactive protein, IL-8 interleukin-8
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older individuals [27]. In healthy women, IGF-1 and ratio
of IGF-1/IGFBP-3 were associated with maximum power
output [28]. Resting level of S-IGF-1 declines with aging
together with sarcopenia and osteopenia [10, 29], and it is
low in chronic and severe diseases [30]. An increase
of S-IGF-1, ranging from ~10 to 30%, has been measured
after 5–10 min of high-intensity bouts of exercise in
healthy individuals [21]. Mechanisms regulating the con-
centration of IGF-1 are complex, and the transient in-
crease during a bout of exercise returns to baseline within
one hour [21]. This may involve uptake into peripheral tis-
sues [31] and uptake into the central nervous system [32].
The reduced levels of free IGF-1 may be due to activity
induced uptake of IGF-1 from the blood. IGF-1 is ac-
tively taken up from blood into the central nervous sys-
tem via the blood brain barrier and via the choroid
plexus. Uptake of IGF-1 over the blood brain barrier is
stimuli-dependent and coupled with increased neuronal
activity [32]. Both aerobic exercise and systemic injec-
tion of IGF-1 increase cerebrospinal levels of IGF-1
without alterations in serum levels in rats [13]. It has
therefore been suggested that serum levels of IGF-1 may
be rapidly normalized due to strong uptake into the
brain [33] and IGF-1 uptake may be increased by the
physical activity. There is also evidence of re-uptake of
IGF-1 into peripheral muscle after exercise [31]. The
present study would indicate that both mobilisation of
IGF-1 into the blood and possible active re-uptake into
tissues after exercise is preserved in FM patients. As ex-
pected, the patients with FM showed a lower pain
threshold [1] and higher ratings of pain and fatigue in
legs and global fatigue at baseline. A notable increase of
local fatigue was found already during exercise at mod-
erate intensity. This finding is in line with a previous
study reporting that physical exercise induces fatigue in
FM [34]. The lean mass, which mainly reflects the skel-
etal muscle mass, was similar in both groups of the
present study. However, BMI and body fat content were
higher in the patients than the controls. This might con-
tribute to the higher self-reported fatigue, during exer-
cise. In a previous study, increased levels of S-IGF-1
after 15 weeks of aerobic exercise was found in lean but
not in overweight and obese patients with FM [14]. Fur-
thermore, BMI was associated with CRP in FM. This im-
plies a peripheral low-grade inflammation and could
potentially contribute to reduced muscular IGF-1 re-
sponse in overweight women with FM [35–37]. How-
ever, in the present study, BMI did not correlate with
the acute IGF-1 response.
The exercise load was defined by means of the RPE
scale, a method recommended for determining exercise
intensity [38]. The ratings of exertion showed that both
groups followed the protocol at the two test occasions,
without any significant differences for the rating of
exertion, and therefore the groups were comparable.
Walking on flat ground indoors with a velocity of 4 km/h
for a person with a bodyweight of 70 kg corresponds to
approximately 50 W. All the participants were able to
carry on a normal conversation without any notable im-
pact on their breathing rate. Thus, the exercise load corre-
sponded to a moderate exercise level. In women with FM,
the exercise load remained at 50 W also at the end of the
exercise period.
Previous studies have shown that women with FM
have a lower muscular physical fitness when compared
to healthy women [2, 39]. This might explain why
women with FM cycled at a significantly lower exercise
load than the healthy reference group in the present
study. The patients with FM also reported less hours
spent on vigorous exercise during their leisure time,
compared to the reference group, in line with previous
studies [6].
Conclusions
Fifteen minutes of exercise at moderate intensity was
sufficient to achieve an increase in total S-IGF-1 and its
binding protein, S-IGFBP-3. Hence, patients with FM
were able to activate their skeletal muscle metabolism
during a short, moderate bout of exercise, despite of
their pain and fatigue. This knowledge is of importance
for clinical rehabilitation of patients with FM who com-
monly exercise at this level, rather than at a high inten-
sity level.
Abbreviations
BMI: Body mass index; FIQ: Fibromyalgia impact questionnaire;
FM: Fibromyalgia; free IGF-1: Free insulin-like growth factor-1; IGFBP-3: Serum
insulin-like growth factor binding protein-3; IL-8: Interleukin-8; kJ: Kilojoules;
kPa: Kilopascal; RPE: Reported perceived exertion; sCRP: Serum C-reactive
protein; S-IGF-1: Serum total insulin-like growth factor-1; W: Watt
Acknowledgements
We thank Karolina Thörn for her skillful technical assistance with immunological
analysis of protein levels, and Sahlgrenska University Hospital/Physiotherapy,
where the two exercise tests were conducted.
Funding
The study was supported by the Swedish Rheumatism Association, the
Swedish Research Council, ALF-LUA at Sahlgrenska University Hospital, the
Wilhelm and Martina Lundgrens Foundation, and Rune and Ulla Amlövs
Trust. The funding sources played no role in protocol development, study
conduct, interpretation of results, or the decision to submit the manuscript
for publication.
Availability of data and materials
Dataset is not stored in an open access repository. We will share data with
any investigator interested in replicating these findings or interested in
future collaborations, pursuant to institutional and legal regulations, in
accordance with patient privacy and confidentiality.
Authors’ contributions
The authors of this study have contributed as follows: KM worked with study
conception, design, data acquisition, data analysis, interpretation of data and
first draft of manuscript; KL worked with study conception, design, data
analysis, interpretation of data and first draft of manuscript; AL worked with
data analysis, interpretation of data and first draft of manuscript; OA worked
Mannerkorpi et al. BMC Musculoskeletal Disorders  (2017) 18:37 Page 6 of 8
with study design, acquisition, and first draft of manuscript, ÅC worked with
study design, acquisition and first draft of manuscript, JB worked with study
conception, design, data analysis, interpretation of data and first draft of
manuscript. All the authors were involved in writing the manuscript and
revising it critically for important intellectual content. All the authors
approved the final version of the article.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study was approved by the Regional Ethical Review Board at the
University of Gothenburg, in Gothenburg, Sweden. Verbal information was
given to all subjects, and written consent was obtained from all of them.
Author details
1Institute of Neuroscience and Physiology, Section of Health and
Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg,
Sweden. 2Sahlgrenska University Hospital, Physiotherapy and Occupational
therapy, Göteborg, Sweden. 3Department of Rheumatology and
Inflammation Research, Institute of Medicine, Sahlgrenska Academy,
University of Gothenburg, Guldhedsgatan 10, Box 480, 40530 Göteborg,
Sweden. 4Section of Endocrinology, Sahlgrenska Academy, Sahlgrenska
University Hospital, Institution of Medicine, University of Gothenburg,
Gothenburg, Sweden. 5Sahlgrenska University Hospital, Rheumatology,
Göteborg, Sweden.
Received: 28 June 2016 Accepted: 14 January 2017
References
1. Wolfe F, Smythe H, Yunus M, Bennet RM, Bombardier C, Goldenberg DL,
et al. The American College of Rheumatology 1990 criteria for the
classification of fibromyalgia. Report of the Multicenter Criteria Committee.
Arthritis Rheum. 1990;33:160–72.
2. Mannerkorpi K, Burckhardt C, Bjelle A. Physical performance characteristics
of women with fibromyalgia. Arthritis Care Res. 1994;7:123–9.
3. Lannersten L, Kosek E. Dysfuntion of endogenous pain inhibitionduring
exercise with painful muscles in patients with shouldre myalgia and
fibromyalgia. Pain. 2010;15:77–86.
4. Staud R, Robinson ME, Price DD. Isometric exercise has opposite effects on
central pain mechanisms in fibromyalgia patients compared to normal
controls. Pain. 2005;118:176–84.
5. Mcloughlin M, Colbert L, Stegner A, Cook D. Are women with fibromyalgia
less physically active than healthy women? Med Sci Sports Exerc.
2011;43:905–12.
6. Segura-Jimenez V, Alvarez-Gallardo I, Estevez-Lopez F, Soriano-Maldonado A,
Soriano-Maldonado A, Ortega FB, et al. Differences in sedentary time and
physical activity between female patients with fibromyalgia and healhty
controls. Arthritis Rheum. 2015;67(11):3047–57.
7. Busch A, Webber S, Brachaniec M, Bidonde J, Dal Bello-Haas V, Danyliw A, et
al. Exercise therapy for fibromyalgia. Curr Pain Headache Rep.
2011;15:358–67.
8. Bennett RM. Adult growth hormone deficiency in patients with
fibromyalgia. Curr Rheumatol Rep. 2002;4:306–12.
9. Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Sola J,
Casanueva FF, et al. High prevalence of growth hormone deficiensy in
severe fibromyalgia syndromes. J Clin Endorcrinol Metab. 2010;95:4331–7.
10. Landin-Wilhelmsen K, Lundberg P, Lappas G, Wilhelmsen L. Insulin-like
growth factor I levels in healthy adults. Horm Res. 2004;62 suppl 1:8–16.
11. Philippou A, Maridaki M, Halapas A, Koutsilieris M. The role of the
insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo.
2007;21(1):45–54.
12. Nindl BC, Pierce JR. Inslulin-like growth factor I as a biomarker of health,
fitness and training status. Med Sci Sports Exerc. 2010;42:39–49.
13. Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin-like
growth factor I mediates effects of exercise on the brain. J Neurosci.
2000;20:2926–33.
14. Bjersing JL, Erlandsson M, Bokarewa MI, Mannerkorpi K. Exercise and obesity
in fibromyalgia. Beneficial roles of insulin-like growth factor 1 and resistin?
Arthritis Res Ther. 2013;15:R34.
15. Thomas BJ, Cornish BH, Ward LC. Bioelectrical impedance analysis for
measurement of body fluid volumes: a review. J Clin Eng. 1992;17(6):505–10.
16. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, et al.
Bioelectrical impedance analysis—part I: review of principles and methods.
Clin Nutr. 2004;23(5):1226–43.
17. Borg G. Borg’s perceived exertion and pain scales. Leeds: Human Kinetics;
1998.
18. Åstrand P, Rodahl K, Dahl H. Stromme S. Textbook of Work Physiology. 4th
Ed. United States: Human Kinetics Publishers; 2003.
19. Kosek E, Ekholm J, Nordeman R. A comparison of pressure pain thresholds
in different tissues and body regions. Scand J Rehabil Med. 1993;23:117–24.
20. Burckhardt C, Clark S, Bennet R. The Fibromyalgia Impact Questionnaire.
Development and validation. J Rheumatol. 1991;18:728–33.
21. Berg U, Bang P. Exercise and circulating insulin-like growth factor 1. Horm
Res. 2004;6250–58(suppl1):50–8.
22. Cappon J, Brasel J, Mohan S, Cooper D. Effect of brief exercise on circulating
insulin-like growth factor I. J Appl Physiol. 1994;76(6):2490–6.
23. Butler A, Yakar S, Leroith D. Insulin-like growth factor-I: compartmentalization
within the somatotropic axis? News Physiol Sci. 2002;17:82–5.
24. Kramer W, Aguilera B, Terada M, Newton RU, Lynch JM, Rosendaal C, et al.
Responses of IGF-1 to endogenous increases in growth hormone after
heavy resistance exercise. J Appl Physiol. 1995;79(4):1310.
25. Brahm H, Piehl-Aulin K, Saltin B, Ljunghall S. Net fluxes over working thigh
of hormones, growth factors and biomarkers of bone metabolism during
short lasting dynamic exercise. Calcif Tissue Int. 1997;60(2):175–80.
26. Nindl B, Santtila M, Vaara J, Hakkinen K, Kyrolainen H. Circulating IGF-I is
associated with fitness and health outcomes in a population of 846 young
healthy men. Growth Horm IGF Res. 2011;21(3):124–8.
27. Taekema D, Ling C, Blauw G, Meskers CG, Westendorp RGJ, de Craen AJM,
et al. Circulating levels of IGF1 are associated with muscle strength in
middle-aged- and oldest-old women. Eur J Endocrinol. 2011;164:189–96.
28. Glaser S, Friedrich N, Ewert R, Schaper C, Krebs A, Dorr M, et al. Association
of circulating IGF-I and IGFBP-3 concentrations and exercise capacity in
healthy volunteers: results of the Study of Health in Pomerania. Growth
Horm IGF Res. 2010;20(6):404–10.
29. Perrini S, Laviola L, Carreira M, Cignarelli A, Natalicchio A, Giorgino F. The
GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms
underlying age-related skeletal muscle wasting and osteoporosis. J
Endocrinol. 2010;205(June 1):201–10.
30. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G,
Lundberg PA, et al. Serum insulin-like growth factor I in a random
population sample of men and women: relation to sex, smoking habits,
coffee consumption and physical activity, blood pressure and
concentrations of plasma lipids, fibrinogen, parathyroid hormone and
osteocalcin. Clin Endocrinol (Oxf). 1994;41:351–7.
31. Eliakim A, Moromisato M, Moromisato D, Brasel J, Roberts Jr C, Cooper D.
Increase in muscle IGF-I protein but not IGF-I mRNA after 5 days of
endurance training in young rats. Am J Physiol. 1997;273:R1557–61.
32. Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U, et al.
Neuronal activity drives localized blood-brain-barrier transport of serum
insulin-like growth factor-I into the CNS. Neuron. 2010;67(5):834–46.
33. Walsh J, Scribbans T, Bentley R, Kellawan J, Gurd B, Tschakovsky M.
Neurotrophic growth factor responses to lower body resistance training in
older adults. Appl Physiol Nutr Metab. 2016;41(3):315–23.
34. Christidis N, Ghafouri B, Larsson A, Larsson A, Palstam A, Mannerkorpi K,
et al. Comparison of the Levels of Pro-Inflammatory Cytokines Released in
the Vastus Lateralis Muscle of Patients with Fibromyalgia and Healthy
Controls during Contractions of the Quadriceps Muscle–A Microdialysis
Study. Plos One. 2015;10(12):e0143856.
35. Ortega E, Garcia JJ, Bote ME, Martin-Cordero L, Escalante Y, Saavedra JM,
et al. Exercise in fibromyalgia and related inflammatory disorders: known
effects and unknown chances. Exerc Immunol Rev. 2009;15:42–65.
36. Hussey S, Lum H, Alvarez A, Cipriani Y, Garduño-Garcia J, Anaya L, et al. A
sustained increase in plasma NEFA upregulates the Toll-like receptor
network in human muscle. Diabetologia. 2014;57(3):582–91.
37. Amouzou C, Breuker C, Fabre O, Bourret A, Lambert K, Birot O, et al. Skeletal
muscle insulin resistance andabsence of inflammation characterizeinsulin-
resistant grade i obese women. Plos One. 2016;11(4):e0154119.
Mannerkorpi et al. BMC Musculoskeletal Disorders  (2017) 18:37 Page 7 of 8
38. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM,
et al. American College of Sports Medicine position stand. Quantity and
quality of exercise for developing and maintaining cardiorespiratory,
musculoskeletal, and neuromotor fitness in apparently healthy adults:
guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59.
39. Maquet D, Croisier J, Renard C, Crielaard J. Muscle performance in patients
with fibromyalgia. Joint Bone Spine. 2002;69:293–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Mannerkorpi et al. BMC Musculoskeletal Disorders  (2017) 18:37 Page 8 of 8
